Amprius Technologies (NYSE:AMPX) Stock Price Down 4.1% – Should You Sell?

Amprius Technologies, Inc. (NYSE:AMPX)’s share price traded down 4.1% on Thursday . The stock traded as low as $9.94 and last traded at $10.19. 5,338,940 shares were traded during trading, a decline of 35% from the average daily volume of 8,266,377 shares. The stock had previously closed at $10.63.

Analysts Set New Price Targets

Several research firms recently commented on AMPX. Wall Street Zen cut Amprius Technologies from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. JonesTrading began coverage on Amprius Technologies in a research note on Friday, July 10th. They set a “buy” rating and a $30.00 price objective on the stock. Roth Capital restated a “buy” rating on shares of Amprius Technologies in a report on Friday, May 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Amprius Technologies in a research note on Friday, July 17th. Finally, Zacks Research upgraded Amprius Technologies from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 4th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $23.00.

Amprius Technologies Trading Down 4.1%

The firm has a market capitalization of $1.44 billion, a PE ratio of -35.14 and a beta of 2.33. The business has a fifty day moving average price of $12.12 and a two-hundred day moving average price of $14.94.

Insider Buying and Selling at Amprius Technologies

In other Amprius Technologies news, CTO Constantin Ionel Stefan sold 3,208 shares of the company’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $17.19, for a total value of $55,145.52. Following the transaction, the chief technology officer owned 801,310 shares of the company’s stock, valued at $13,774,518.90. This represents a 0.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Donald R. Dixon sold 85,000 shares of the stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $17.17, for a total transaction of $1,459,450.00. Following the transaction, the director directly owned 359,380 shares of the company’s stock, valued at approximately $6,170,554.60. This trade represents a 19.13% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 152,834 shares of company stock valued at $2,723,382 over the last 90 days. 5.10% of the stock is owned by insiders.

Institutional Trading of Amprius Technologies

Several institutional investors have recently added to or reduced their stakes in the stock. Oppenheimer & Co. Inc. raised its position in Amprius Technologies by 47.7% in the fourth quarter. Oppenheimer & Co. Inc. now owns 442,090 shares of the company’s stock valued at $3,488,000 after purchasing an additional 142,751 shares during the period. Stephens Investment Management Group LLC boosted its position in shares of Amprius Technologies by 33.1% during the fourth quarter. Stephens Investment Management Group LLC now owns 1,441,698 shares of the company’s stock worth $11,375,000 after buying an additional 358,791 shares during the period. Hussman Strategic Advisors Inc. purchased a new position in shares of Amprius Technologies during the fourth quarter worth $1,657,000. Vanguard Group Inc. grew its stake in shares of Amprius Technologies by 9.5% in the fourth quarter. Vanguard Group Inc. now owns 7,128,657 shares of the company’s stock valued at $56,245,000 after buying an additional 616,037 shares in the last quarter. Finally, UBS Group AG grew its stake in shares of Amprius Technologies by 35.5% in the fourth quarter. UBS Group AG now owns 2,098,946 shares of the company’s stock valued at $16,561,000 after buying an additional 549,892 shares in the last quarter. Institutional investors and hedge funds own 5.04% of the company’s stock.

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.